These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 17269483)

  • 1. EGFR artifactual mutations associated with two DNA sequencers.
    Yu JJ; Flynn DC
    Biotechniques; 2007 Jan; 42(1):41. PubMed ID: 17269483
    [No Abstract]   [Full Text] [Related]  

  • 2. Epidermal growth factor receptor mutations in small cell lung cancer.
    Tatematsu A; Shimizu J; Murakami Y; Horio Y; Nakamura S; Hida T; Mitsudomi T; Yatabe Y
    Clin Cancer Res; 2008 Oct; 14(19):6092-6. PubMed ID: 18829487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted sequencing with enrichment PCR: a novel diagnostic method for the detection of EGFR mutations.
    Kang S; Kim BG; Han HH; Lee JH; Kim JE; Shim HS; Cho NH
    Oncotarget; 2015 May; 6(15):13742-9. PubMed ID: 25915533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of 2-year experience with EGFR mutation analysis of small diagnostic samples.
    Hlinkova K; Babal P; Berzinec P; Majer I; Mikle-Barathova Z; Piackova B; Ilencikova D
    Diagn Mol Pathol; 2013 Jun; 22(2):70-5. PubMed ID: 23628817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of epidermal growth factor receptor and human epidermal growth factor receptor 2 activating mutations in lung adenocarcinoma by high-resolution melting amplicon analysis: correlation with gene copy number, protein expression, and hormone receptor expression.
    Willmore-Payne C; Holden JA; Layfield LJ
    Hum Pathol; 2006 Jun; 37(6):755-63. PubMed ID: 16733218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Experience on epidermal growth factor receptor gene mutation analysis in non-small cell lung cancer].
    Zhang J; Gao J; Liang ZY; Liu TH
    Zhonghua Bing Li Xue Za Zhi; 2011 Oct; 40(10):712-4. PubMed ID: 22321558
    [No Abstract]   [Full Text] [Related]  

  • 7. EGFR Mutation status in Japanese lung cancer patients: genotyping analysis using LightCycler.
    Sasaki H; Endo K; Konishi A; Takada M; Kawahara M; Iuchi K; Matsumura A; Okumura M; Tanaka H; Kawaguchi T; Shimizu T; Takeuchi H; Yano M; Fukai I; Fujii Y
    Clin Cancer Res; 2005 Apr; 11(8):2924-9. PubMed ID: 15837743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of EGFR mutation status between plasma and tumor tissue in non-small cell lung cancer using the Scorpion ARMS method and the possible prognostic significance of plasma EGFR mutation status.
    Duan H; Lu J; Lu T; Gao J; Zhang J; Xu Y; Wang M; Wu H; Liang Z; Liu T
    Int J Clin Exp Pathol; 2015; 8(10):13136-45. PubMed ID: 26722512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analytic and Clinical Validation of an Ultrasensitive, Quantitative Polymerase Chain Reaction Assay for EGFR Mutation Analysis With Circulating Tumor DNA.
    Wang X; Gao Y; Wang B; Zhang Z; Liang C; Feng H; Guo Y; Da J; Mo M; Zhang M; Ding F; Chen Z; Li H; Liu D
    Arch Pathol Lab Med; 2017 Jul; 141(7):978-984. PubMed ID: 28537806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sea-urchin-like Au nanocluster with surface-enhanced raman scattering in detecting epidermal growth factor receptor (EGFR) mutation status of malignant pleural effusion.
    Wang L; Guo T; Lu Q; Yan X; Zhong D; Zhang Z; Ni Y; Han Y; Cui D; Li X; Huang L
    ACS Appl Mater Interfaces; 2015 Jan; 7(1):359-69. PubMed ID: 25495142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytology smears as diagnostic material for EGFR gene testing in non-small cell lung cancer.
    Powrózek T; Krawczyk P; Pankowski J; Reszka K; Jakubiak M; Obrochta A; Wojas-Krawczyk K; Buczkowski J; Milanowski J
    Tumori; 2015 Nov; 101(6):e151-3. PubMed ID: 26108238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Consistent mutation status within histologically heterogeneous lung cancer lesions.
    Mattsson JS; Imgenberg-Kreuz J; Edlund K; Botling J; Micke P
    Histopathology; 2012 Oct; 61(4):744-8. PubMed ID: 22458769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphorylation status of epidermal growth factor receptor is closely associated with responsiveness to gefitinib in pulmonary adenocarcinoma.
    Hijiya N; Miyawaki M; Kawahara K; Akamine S; Tsuji K; Kadota J; Akizuki S; Uchida T; Matsuura K; Tsukamoto Y; Moriyama M
    Hum Pathol; 2008 Mar; 39(3):316-23. PubMed ID: 18261621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Good response to gefitinib in a lung adenocarcinoma harboring a heterozygous complex mutation of L833V and H835L in epidermal growth factor receptor gene.
    Yang TY; Tsai CR; Chen KC; Hsu KH; Lee HM; Chang GC
    J Clin Oncol; 2011 Jun; 29(16):e468-9. PubMed ID: 21422421
    [No Abstract]   [Full Text] [Related]  

  • 15. Increased epidermal growth factor receptor (EGFR) gene copy number is strongly associated with EGFR mutations and adenocarcinoma in non-small cell lung cancers: a chromogenic in situ hybridization study of 182 patients.
    Chang JW; Liu HP; Hsieh MH; Fang YF; Hsieh MS; Hsieh JJ; Chiu YT; Tsai HY; Chen YH; Chen YT; Hsu HY; Chen YT; Tsai SF; Chen YR; Hsi BL; Huang SF
    Lung Cancer; 2008 Sep; 61(3):328-39. PubMed ID: 18304690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidermal growth factor receptor status in anaplastic thyroid carcinoma.
    Lee DH; Lee GK; Kong SY; Kook MC; Yang SK; Park SY; Park SH; Keam B; Park DJ; Cho BY; Kim SW; Chung KW; Lee ES; Kim SW
    J Clin Pathol; 2007 Aug; 60(8):881-4. PubMed ID: 17079354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous detection of multiple mutations in epidermal growth factor receptor based on fluorescence quenching of quantum dots.
    Kang T; Lee H; Choe D; Joo SW; Lee SY; Yoon KA; Lee K
    Biosens Bioelectron; 2012 Jan; 31(1):558-61. PubMed ID: 22078844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation status of receptor tyrosine kinase downstream pathways in primary lung adenocarcinoma with reference of KRAS and EGFR mutations.
    Hiramatsu M; Ninomiya H; Inamura K; Nomura K; Takeuchi K; Satoh Y; Okumura S; Nakagawa K; Yamori T; Matsuura M; Morikawa T; Ishikawa Y
    Lung Cancer; 2010 Oct; 70(1):94-102. PubMed ID: 20117855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical relevance of EGFR- and KRAS-status in colorectal cancer patients treated with monoclonal antibodies directed against the EGFR.
    Heinemann V; Stintzing S; Kirchner T; Boeck S; Jung A
    Cancer Treat Rev; 2009 May; 35(3):262-71. PubMed ID: 19117687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EGFR pathway subgroups in Chilean colorectal cancer patients, detected by mutational and expression profiles, associated to different clinicopathological features.
    Alvarez K; Orellana P; Villarroel C; Contreras L; Kawachi H; Kobayashi M; Wielandt AM; De la Fuente M; Triviño JC; Kronberg U; Carvallo P; López-Köstner F
    Tumour Biol; 2017 Sep; 39(9):1010428317724517. PubMed ID: 28936923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.